期刊文献+

原发性高血压并高尿酸血症与C反应蛋白关系探讨 被引量:6

Relationship between essential hypertension with elevated uric acid and levels of C-reactive protein
下载PDF
导出
摘要 [目的 ]探讨原发性高血压并高尿酸血症与血清C反应蛋白 (CRP)浓度的关系。 [方法 ]对5 0名原发性高血压患者 (包括尿酸高与尿酸正常 )及 5 0名健康人检查 ,测CRP浓度与尿酸浓度及其他生化指标 ,比较血尿酸高、血尿酸正常及正常对照组血清CRP浓度的差异。 [结果 ]原发性高血压并高尿酸血症组CRP浓度 (6 .31± 2 .6 0 )mg/L及尿酸正常组高血压患者CRP浓度 (2 .80±1.95 )mg/L均高于正常对照组CRP浓度 (1.2 4± 1.2 6 )mg/L ,两者分别与正常对照组比较有显著性差异 (P <0 .0 1) ;原发性高血压并高尿酸血症组CRP浓度高于尿酸正常组高血压患者CRP浓度 ,两者比较有显著性差异 (P <0 .0 1)。 [结论 ]原发性高血压患者血清CRP浓度升高 ,且其血清尿酸浓度与CRP浓度呈正相关关系 (r =0 .6 2 2 ,P <0 .0 1)。 [Objective] To investigate the relationship between essential hypertension with elevated uric acid and levels of C-reactive protein (CRP). [Methods] By measured 50 essential hypertension patients and 50 healthy people with the level of CRP and the other biochemistry tests. Compared the relationship of CRP among essential hypertension with elevated uric acid, normal uric acid and healthy people. Results :The level of CRP(6.31±2.60)mg/L of essential hypertension patients with elevated uric acid and the level of CRP(2.80±1.95)mg/L of the normal uric ones are higher than that of the healthy people (1.24±1.26) mg/L, both of them have remarkable differences (P< 0.01 ); The level of CRP of essential hypertension patients with elevated uric acid is higher than the level of CRP of the normal uric acid ones, both of them have remarkable differences (P< 0.01); [Conclusions] Serum CRP level of essential hypertension patients is higher than that of healthy people, serum uric acid level is positive associated with CRP level (r=0.622,P<0.01).
出处 《大连医科大学学报》 CAS 2004年第4期290-292,共3页 Journal of Dalian Medical University
关键词 原发性高血压 C反应蛋白 尿酸 炎症 essential hypertension C-reactive protein uric acid inflammation
  • 相关文献

参考文献3

二级参考文献33

  • 1Gertler MM, Garn SM, Levine SA. Serum Uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med, 1951,34 : 1421-1431.
  • 2Beard Jt. Serum uric acid and coronary heart disease. Am Heart J,1983,106:397-400.
  • 3Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients.Hypertension, 1999,34 : 144-150.
  • 4Bickel C, Rupprecht HI, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographical]y proven coronary artery disease. Am J Cardiol, 2002,89:12-17.
  • 5Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol, 1985,121 : 11 -18.
  • 6Bonora E, Targher G, Zenete MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atheroaclerosis Risk Factors Study. Int J Obes Relat Metab Disord,1996,20:975-980.
  • 7Rathmann W, Funkhouser E, Dyer R, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study.Coronary Artery Risk Development in Young Adults. Ann Epidemiol, 1998,8:250-261.
  • 8Ward HI. Uric acid as an independent risk factor in the treatment of hypertension.Lancet, 1998,352:670-671.
  • 9DeScheeder IK, van de Kraay AM, Lamers JM, et al. Myocardial malodialdehyde and uric acid release after short-lasting coronaryy occlusions during angioplasty: potential mechanisms for free radical generation. Am J Cardiol, 1991,68:392-395.
  • 10Ginsberg MH, Kozin F, O'Malley M. et al. Release of platelet constituents by monosodium urate crystals. J Clin Invest, 1997,60:999-1007.

共引文献735

同被引文献81

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部